nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0245	0.0245	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0245	0.0245	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0207	0.0207	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0207	0.0207	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0201	0.0201	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0185	0.0185	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0179	0.0179	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.017	0.017	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0156	0.0156	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.0152	0.0152	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0135	0.0135	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.012	0.012	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00952	0.00952	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00935	0.00935	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00935	0.00935	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00915	0.00915	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00896	0.00896	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00884	0.00884	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00868	0.00868	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00863	0.00863	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00778	0.00778	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00773	0.00773	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00757	0.00757	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00742	0.00742	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00742	0.00742	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00706	0.00706	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00706	0.00706	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00682	0.00682	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00682	0.00682	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00658	0.00658	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.00642	0.00642	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.00642	0.00642	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00627	0.00627	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00627	0.00627	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.0062	0.0062	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.0058	0.0058	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00577	0.00577	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00577	0.00577	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00565	0.00565	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00565	0.00565	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00542	0.00542	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00542	0.00542	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00524	0.00524	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00521	0.00521	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.00517	0.00517	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.0049	0.0049	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.00478	0.00478	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.00478	0.00478	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00447	0.00447	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00441	0.00441	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.0044	0.0044	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.00399	0.00399	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.00397	0.00397	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.00386	0.00386	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.00379	0.00379	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.00379	0.00379	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00377	0.00377	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.00372	0.00372	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.0035	0.0035	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PENK—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.00245	0.00245	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.00245	0.00245	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TRH—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PENK—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TRH—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CHKB—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPS—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPS—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000871	0.000871	CbGpPWpGaD
